[1] Mercieri M, Palmisani S, De Blasi R A, et al. Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: a double-blind, randomized, active-controlled trial [J] .Br J Anaesth,2017,119(4):792-802.
[2] 李 燕,王国年,林 鹰,等.NMDAR在瑞芬太尼引起痛觉敏化机制和防治的研究进展[J].现代生物医学进展,2015,15(6):1148-1150,1164.
[3] Campillo A, Gonzalez-Cuello A, Cabanero D, et al. Increased spinal dynorphin levels and phosphor-extrancellular signal-regulated kinases 1 and 2 c-Fos immunoreactivity after surgery under remifentanil anesthesia in mice [J].Mol Pharmacol,2010,77(2):185-194.
[4] Corder G, Tawfik V L, Wang D, et al. Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia[J]. Nat Med,2017, 23:164-173.
[5] Virk M S, Williams J T. Agonist-specific regulation of μ-opioid receptor desensitization and recovery from desensitization[J]. MolPharmacol, 2008,73(4):1301-1308.
[6] Marc D K, Patricia L H, Hilde W. The short-lasting analgesia and long-term antihyperalgesic effect of intrathecal clonidine in patients undergoing colonic surgery [J]. Anesth Analg,2005,101(2):566-572.
[7] Roeckel L A, Le C GM, Gavériaux-Ruff C, et al. Opioid-induced hyperalgesia: Cellular and molecular mechanisms[J]. Neuroscience,2016, Dec 3,338:160-182.
[8] Lee M,Silverman S M,Hansen H,et al. A comprehensive review of opioid-induced hyperalgesia [J]. Pain Physician, 2011,14(2):145-161.
[9] Dogrul A, Bilsky E J, Ossipov M H, et al. Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance [J]. AnesthAnalg,2005,101(6):1730-1735.
[10] Yuan Yuan, Wang Jingyao, Yuan Fang, et al. Glycogen synthase kinase-3βcontributes to remifentanil-induced postoperative hyperalgesia via regulating N-Methyl-d-Aspartate receptor trafficking[J].Anesth Analg,2013,116(2):473-481.
[11] Chu L F, D’Arcy N, Brady C, et al. Analgesic tolerance without demonstrable opioid-induced hyperalgesia:a double-blinded, randomized, placebo-controlled trialof sustained-release morphine for treatment of chronicnonradicular low-back pain [J].Pain,2012,153:1583-1592.
[12] Comelon M, Raeder J, Stubhaug A, et al. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia [J].Br J Anaesth,2016,116:524-530.
[13] Zhao M, Joo D T. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance [J]. Anesthesiology,2008,109(2):308-317.
[14] Lena W, David C Y, Alexander T. Opioid-induced hyperalgesia in clinical anesthesia practice: what has remained from theoretical concepts and experimental studies?[J].Curr Opin Anesthesiol, 2017, 30:458-465.
[15] Chu L F, Dairmont J, Zamora A K et al.The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia[J]. J Pain,2011,12(1):108-115.
[16] Nama S, Meenan D R, Fritz W T.The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS[J].Pain Physician,2010,13(4):365-368.
[17] Amr Y M.Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: aprospective,randomized,double blind trial [J]. Pain Physician,2010,13(3):245-249.
[18] 马越涛. 脊髓水平环氧合酶在切口痛大鼠术后痛觉敏化中的作用 [D].沈阳:中国医科大学,2007.
[19] 舒海华,李桥波,叶 芳,等. 环氧化酶-2抑制剂帕瑞昔布对急性芬太尼诱导的大鼠痛觉敏化的抑制作用 [J]. 实用医学杂志,2015,31(5):711-714.
[20] Yuguang H,Xia J,Hailan W,et al. Ketamine and lornoxicam for preventing a fentanyl-induced increase in postoperative morphine requirement.[J]. Anesth Analg,2008,107(6):2032-2037.
[21] Q B Li, L Chang, F Ye, et al. Role of spinal cyclooxygenase-2 and prostaglandin E2 in fentanyl-induced hyperalgesia in rats[J]. Br J Anaesth, 2018,120 (4): 827-835
[22] 苏志源, 陈郡兴, 谭正玲, 等. 帕瑞昔布钠抑制瑞芬太尼术后痛觉敏化的量效关系[J]. 临床医学工程,2011, 18 (4):528-529.
[23] Kroin J S,Takatori M,Li J,et al. Upregulation of dorsal horn microglial cyclooxygenase-1 and neuronal cyclooxygenase-2 after thoracic deep muscle incisions in the rat [J]. Anesth Analg, 2008,106(4):1288-1295.
[24] Cristina S, Alberto N, Claudia C, et al. Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies[J]. Local and Reg Anesth, 2018,11:15-23.
[25] Marion L, Sanford S, Hans H. A comprehensive review of opioid-induced hyperalgesia[J]. Pain Physician,2011,14(2):145-161.
[26] Selpeter S R, Buckley J S, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia[J].J Palliat Med,2013,16(6):616-622.
[27] Wang H, Wang Z, Mi W, et al. Propofol effectively inhibits lithium-pilocarpine-induced status pilepticus in rats via downregulation of N-methyl-D-aspartate receptor 2B subunit expression[J].Neural Regen Res,2012, 7(11):827-832.
[28] 杜奕鹏,姜凤鸣,崔瑞岑,等.右美托咪定复合曲马多预防瑞芬太尼复合麻醉患者术后痛觉敏化的效果[J].中华麻醉学杂志,2015,35(2):249-250.
[29] 王永丽,迟 蕾,赵国梁,等.持续泵注右美托咪定对瑞芬太尼麻醉术后痛觉敏化的影响[J].实用医药杂志,2015,32(11):996-998.